In the words of Cleveland HeartLab CEO Jake Orville, business has “exploded” since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a fee-for-service model. Cleveland HeartLab is a CLIA-certified and CAP-accredited reference lab that does an array of lipid and inflammation tests for clients, including CardioMPO, a proprietary test for cardiac inflammation marker myeloperoxidase.

Cleveland HeartLab LLC has added a test of low-density lipoprotein, the so-called “bad cholesterol,” to its portfolio of heart-inflammation tests.The company’s NMR LipoProfile test measures and counts LDL particles, which carry cholesterol in the blood and can build up on artery walls, leading to atherosclerosis and cardiovascular disease.The [...]

The company plans to use the investment to bolster its sales and marketing efforts and expand its laboratory.